Review



gls1  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc gls1
    Gls1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/pm41708583-113-3-13
    Average 86 stars, based on 1 article reviews
    gls1 - by Bioz Stars, 2026-11
    86/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title:
    Article Snippet: .. The following commercial antibodies and reagents were used in this study: RIPK1 (Cell Signaling Technology, #3493); p-S166 RIPK1 (Biolynx Company, BX60008, mouse specific); MeCP2 (Cell Signaling Technology, #3456); β-actin (TransGen Biotech HC201); A20 (Cell Signaling Technology, #5630); Nox2 (ThermoFisher, PA5-76034); Nox1 (ThermoFisher, PA5-76034); SLC7A11 (Cell Signaling Technology, #12691); Mfn2 (Cell Signaling Technology, #11925); Drp1 (Cell Signaling Technology, #8570); p-S616 Drp1 (Cell Signaling Technology, #4494); PERK (Cell Signaling Technology, #3192); IRE1α (Cell Signaling Technology, #3294); ATF6 (Cell Signaling Technology, #65880); BiP (Abcam, ab21685); p-S51 eIF2α (Cell Signaling Technology, #3398); eIF2α (Cell Signaling Technology, #5324); VGLUT1 (Cell Signaling Technology, #47181); SNAT1 (Cell Signaling Technology, #36057); GLS1 (Cell Signaling Technology, #36057); GluA1 (Sigma-Aldrich, SAB5201086); GluA2/3 (MilliporeSigma, AB1506); anti-rabbit (SouthernBiotech, #4050-05); Iba1 (FUJIFILM, #019-19741); Iba1 (FUJIFILM, #011-27991); CD68 (Bio-Rad, MCA1957); mouseCD11b-APC (BioLegend, #101212); mouseCD45-488 (BioLegend, #103122); DAPI (ThermoFisher, D1306); anti-mouse (Southern Biotech, #1031-05); Recombinant hTNFα (Novoprotein, #C008); 5Z7-Oxozeaenol (Sigma-Aldrich, #O9890); zVAD.fmk (MedChemExpress, HY-16658); Cycloheximide (MCE, HY-12320); SM-164 (MedChemExpress, HY-15989); CellROXTM Orange (ThermoFisher, C10443); Thapsigargin (MedChemExpress, HY-13433); Brefeldin A (MedChemExpress, HY16592); Diphenyleneiodonium chloride (MedChemExpress, HY-100965); 6-Diazo-5-oxo-L-norLeucine (MedChemExpress, HY-108357); BPTES (HY-12683); VAS2870 (MCE, HY-12804); Lucigenin (MCE, HY-D0720); Mito-TrackerTM Red (ThermoFisher, M22425); ER-Tracker Red (ThermoFisher, E34251). ..

    Blocking Assay:

    Article Title: GCDH Promotes Breast Cancer Glutaminolysis Reprogramming by Inducing GLS1 Expression Through Histone Crotonylation at Its Promoter Region
    Article Snippet: Protein levels were quantified, and equal amounts of lysate (20 μg per lane) were resolved on 10% SDS–PAGE gels, followed by transfer onto PVDF membranes (Millipore, IPFL00010). .. After blocking with 5% BSA, membranes were incubated overnight at 4 °C with the following primary antibodies: GCDH (Abcam, ab154192; 1:1000), GLS1 (CST, 12855; 1:1000), H3K27cr (PTM Bio, PTM-502; 1:2000), total H3 (Abcam, ab1791; 1:5000), and GAPDH (Proteintech, 60004-1-Ig; 1:10,000). .. Secondary detection was performed using HRP-linked antibodies (CST, 7074/7076; 1:5000), and chemiluminescent signals were visualized with the ECL Prime kit (Cytiva, RPN2236) on an Amersham Imager 600 system.

    Incubation:

    Article Title: GCDH Promotes Breast Cancer Glutaminolysis Reprogramming by Inducing GLS1 Expression Through Histone Crotonylation at Its Promoter Region
    Article Snippet: Protein levels were quantified, and equal amounts of lysate (20 μg per lane) were resolved on 10% SDS–PAGE gels, followed by transfer onto PVDF membranes (Millipore, IPFL00010). .. After blocking with 5% BSA, membranes were incubated overnight at 4 °C with the following primary antibodies: GCDH (Abcam, ab154192; 1:1000), GLS1 (CST, 12855; 1:1000), H3K27cr (PTM Bio, PTM-502; 1:2000), total H3 (Abcam, ab1791; 1:5000), and GAPDH (Proteintech, 60004-1-Ig; 1:10,000). .. Secondary detection was performed using HRP-linked antibodies (CST, 7074/7076; 1:5000), and chemiluminescent signals were visualized with the ECL Prime kit (Cytiva, RPN2236) on an Amersham Imager 600 system.

    Article Title: Fumarate induces LncRNA-MIR4435-2HG to regulate glutamine metabolism remodeling and promote the development of FH-deficient renal cell carcinoma
    Article Snippet: .. The membranes were incubated with primary antibodies: H3K4me1(Cat.5326 T), H3K4me2(Cat.4658 T), H3K4me3(Cat.4909 T), H3K27ac(Cat.8173 T), STAT1(Cat.14994 T), GLS1(Cat.56750 T), PARP(Cat.9532 T),β-actin (Cat.4967 S) (CST, Boston, MA, USA) overnight at 4 °C. ..

    Cell-Signaling:

    Article Title: K ir 5.1-modulated potassium flux stimulates an anabolic kidney phenotype
    Article Snippet: ACLY , Cell Signaling , 13390. .. GLS1 , Cell Signaling , 56750. .. PDH , Cell Signaling , 3205.

    Article Title: Taurine is a natural suppressor of urea cycle via targeting ASL.
    Article Snippet: Antibodies that recognize TUBULIN (11224-1-AP) and ASL (16645-1-AP) were purchased from Proteintech. .. Antibodies that recognize GLS1 (56750), FOS (2250S) and c-Jun (9165S) were purchased from Cell Signaling Technology. .. Antibody that recognizes PTER (PA520750) was purchased from Thermo Fisher.

    other:




    Similar Products

    96
    MedChemExpress gls1 cb839
    Gls1 Cb839, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/Telaglenastat/pm42984143-88-8-13
    Average 96 stars, based on 1 article reviews
    gls1 cb839 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    95
    MedChemExpress bptes gls1 inhibitor medchemexpress hy
    Bptes Gls1 Inhibitor Medchemexpress Hy, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/BPTES/pm41947198-748-7-10
    Average 95 stars, based on 1 article reviews
    bptes gls1 inhibitor medchemexpress hy - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    MedChemExpress cb 839 gls1 inhibitor medchemexpress hy
    Cb 839 Gls1 Inhibitor Medchemexpress Hy, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/Telaglenastat/pm41947198-748-0-3
    Average 96 stars, based on 1 article reviews
    cb 839 gls1 inhibitor medchemexpress hy - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Proteintech gls1
    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and <t>GLS1</t> in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Gls1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/KGA%2FGAC+Antibody/pmc12948417-238-40-41
    Average 94 stars, based on 1 article reviews
    gls1 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Jackson Laboratory gls1 mice
    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and <t>GLS1</t> in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Gls1 Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/fl+fl+mice+trp53/pmc12948417-199-1-17
    Average 86 stars, based on 1 article reviews
    gls1 mice - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc gls1
    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and <t>GLS1</t> in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Gls1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/pm41708583-113-3-13
    Average 86 stars, based on 1 article reviews
    gls1 - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc gls human
    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and <t>GLS1</t> in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Gls Human, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/Glutaminase-1%2FGLS1+Rabbit+mAb/pm41639460-653-61-62
    Average 94 stars, based on 1 article reviews
    gls human - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc rabbit antigls1
    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and <t>GLS1</t> in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.
    Rabbit Antigls1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/gls1++/Glutaminase-1%2FGLS1+XP+Rabbit+mAb/pm41650851-82-6-10
    Average 94 stars, based on 1 article reviews
    rabbit antigls1 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and GLS1 in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: α -Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models

    doi: 10.1172/JCI172380

    Figure Lengend Snippet: ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and GLS1 in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: The membranes were incubated overnight at 4°C with primary antibodies against SOX9 (Abcam, ab3697; 1:1,000); Collagen II (Abcam, ab85266; 1:1,000); MMP3 (Abcam, ab52915; 1:1,000); MMP13 (Proteintech, 18165-1-AP; 1:1,000); ADAMTS5 (Abcam, ab41037; 1:200); NOS2 (Abcam, ab178945; 1:1,000); SLC1A5 (Sigma, HPA035239; 1:1,000); GLS1 (Proteintech; 12855-1-ap; 1:1,000); GS (Abcam, ab176562; 1:1,000); NF-κB p65 (Santa Cruz Biotechnology; sc-8008; 1:1,000); lamin A/C (Santa Cruz Biotechnology; sc-6215; 1:5,000); phospho-IKKα/β (Cell Signaling Technology; 2694P; 1:1,000); IKKα/β (Abcam, ab178870; 1:1,000); phospho-IκBα (Affinity, AF2002; 1:1,000); IκBα (Affinity, AF5002; 1:1,000); TRAF6 (Santa Cruz Biotechnology; sc-8409; 1:200); K63 Ub (Cell Signaling Technology; 5621S; 1:1,000); and GAPDH (Abcam, ab8245; 1:2,000).

    Techniques: Liquid Chromatography with Mass Spectroscopy, Control, Quantitative RT-PCR, Western Blot, Immunofluorescence, Staining

    ( A and B ) mRNA ( A ) and Western blot ( B ) analysis of the indicated anabolic and catabolic factors in chondrocytes treated with BPTES or IL-1β alone or with combined BPTES and IL-1β for 24 hours. The culture medium contained 4 mM Gln. Blots are representative of 3 independent experiments. Ctrl, control. ( C ) Representative safranin O/fast green staining images and OARSI scores ( n = 8 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( D ) Representative MMP13 and NOS2 IHC staining images and quantification of cells positive for MMP13 and NOS2 ( n = 5 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( E ) Safranin O/fast green staining and OARSI scores in joint sections of mice at 8 weeks after DMM surgery. Ad-Ctrl or Ad- Gls1 was intra-articularly injected once per week for 3 weeks beginning at 10 days after surgery ( n = 8 mice per group). Scale bars: 20 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: α -Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models

    doi: 10.1172/JCI172380

    Figure Lengend Snippet: ( A and B ) mRNA ( A ) and Western blot ( B ) analysis of the indicated anabolic and catabolic factors in chondrocytes treated with BPTES or IL-1β alone or with combined BPTES and IL-1β for 24 hours. The culture medium contained 4 mM Gln. Blots are representative of 3 independent experiments. Ctrl, control. ( C ) Representative safranin O/fast green staining images and OARSI scores ( n = 8 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( D ) Representative MMP13 and NOS2 IHC staining images and quantification of cells positive for MMP13 and NOS2 ( n = 5 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( E ) Safranin O/fast green staining and OARSI scores in joint sections of mice at 8 weeks after DMM surgery. Ad-Ctrl or Ad- Gls1 was intra-articularly injected once per week for 3 weeks beginning at 10 days after surgery ( n = 8 mice per group). Scale bars: 20 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: The membranes were incubated overnight at 4°C with primary antibodies against SOX9 (Abcam, ab3697; 1:1,000); Collagen II (Abcam, ab85266; 1:1,000); MMP3 (Abcam, ab52915; 1:1,000); MMP13 (Proteintech, 18165-1-AP; 1:1,000); ADAMTS5 (Abcam, ab41037; 1:200); NOS2 (Abcam, ab178945; 1:1,000); SLC1A5 (Sigma, HPA035239; 1:1,000); GLS1 (Proteintech; 12855-1-ap; 1:1,000); GS (Abcam, ab176562; 1:1,000); NF-κB p65 (Santa Cruz Biotechnology; sc-8008; 1:1,000); lamin A/C (Santa Cruz Biotechnology; sc-6215; 1:5,000); phospho-IKKα/β (Cell Signaling Technology; 2694P; 1:1,000); IKKα/β (Abcam, ab178870; 1:1,000); phospho-IκBα (Affinity, AF2002; 1:1,000); IκBα (Affinity, AF5002; 1:1,000); TRAF6 (Santa Cruz Biotechnology; sc-8409; 1:200); K63 Ub (Cell Signaling Technology; 5621S; 1:1,000); and GAPDH (Abcam, ab8245; 1:2,000).

    Techniques: Western Blot, Control, Staining, Immunohistochemistry, Injection

    ( A ) IB analysis of K63-linked ubiquitination of TRAF6 in HEK293T cells transfected to express HA-TRAF6 with or without Flag-tagged K63-linked ubiquitin (Flag-K63-Ub) and MYC-tagged UBE2O (MYC-UBE2O). ( B ) Densitometry of the bands in A , showing the ubiquitination (Ub) of TRAF6, presented relative to results obtained with cells transfected to express empty vector, set as 100%. ( C ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 in IL-1β–stimulated chondrocytes in the presence of BPTES. Blots are representative of 3 independent experiments. ( D ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 that was immunoprecipitated and TRAF6 from IL-1β– and DM-αKG–stimulated chondrocytes. ( E ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 immunoprecipitated from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( F ) Protein quantitative analysis of the nuclear p65 from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG for 60 minutes. ( G and H ) Quantitative analysis of qRT-PCR ( G ) and Western blot ( H ) analysis for the indicated anabolic and catabolic factors from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( I ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells at 25 weeks in mice fed a standard diet (SD) or HFD. ( J ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells in Gls1 −/− mice and their Gls1 fl/fl control littermates after DMM surgery. veh, vehicle. ( K ) Schematic depicting the described findings: αKG inhibited the TRAF6 ubiquitination via inducing the expression of UBE2O in OA chondrocytes. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: α -Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models

    doi: 10.1172/JCI172380

    Figure Lengend Snippet: ( A ) IB analysis of K63-linked ubiquitination of TRAF6 in HEK293T cells transfected to express HA-TRAF6 with or without Flag-tagged K63-linked ubiquitin (Flag-K63-Ub) and MYC-tagged UBE2O (MYC-UBE2O). ( B ) Densitometry of the bands in A , showing the ubiquitination (Ub) of TRAF6, presented relative to results obtained with cells transfected to express empty vector, set as 100%. ( C ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 in IL-1β–stimulated chondrocytes in the presence of BPTES. Blots are representative of 3 independent experiments. ( D ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 that was immunoprecipitated and TRAF6 from IL-1β– and DM-αKG–stimulated chondrocytes. ( E ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 immunoprecipitated from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( F ) Protein quantitative analysis of the nuclear p65 from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG for 60 minutes. ( G and H ) Quantitative analysis of qRT-PCR ( G ) and Western blot ( H ) analysis for the indicated anabolic and catabolic factors from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( I ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells at 25 weeks in mice fed a standard diet (SD) or HFD. ( J ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells in Gls1 −/− mice and their Gls1 fl/fl control littermates after DMM surgery. veh, vehicle. ( K ) Schematic depicting the described findings: αKG inhibited the TRAF6 ubiquitination via inducing the expression of UBE2O in OA chondrocytes. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: The membranes were incubated overnight at 4°C with primary antibodies against SOX9 (Abcam, ab3697; 1:1,000); Collagen II (Abcam, ab85266; 1:1,000); MMP3 (Abcam, ab52915; 1:1,000); MMP13 (Proteintech, 18165-1-AP; 1:1,000); ADAMTS5 (Abcam, ab41037; 1:200); NOS2 (Abcam, ab178945; 1:1,000); SLC1A5 (Sigma, HPA035239; 1:1,000); GLS1 (Proteintech; 12855-1-ap; 1:1,000); GS (Abcam, ab176562; 1:1,000); NF-κB p65 (Santa Cruz Biotechnology; sc-8008; 1:1,000); lamin A/C (Santa Cruz Biotechnology; sc-6215; 1:5,000); phospho-IKKα/β (Cell Signaling Technology; 2694P; 1:1,000); IKKα/β (Abcam, ab178870; 1:1,000); phospho-IκBα (Affinity, AF2002; 1:1,000); IκBα (Affinity, AF5002; 1:1,000); TRAF6 (Santa Cruz Biotechnology; sc-8409; 1:200); K63 Ub (Cell Signaling Technology; 5621S; 1:1,000); and GAPDH (Abcam, ab8245; 1:2,000).

    Techniques: Ubiquitin Proteomics, Transfection, Plasmid Preparation, Western Blot, Immunoprecipitation, Quantitative RT-PCR, Immunohistochemistry, Control, Expressing

    ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and GLS1 in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: α -Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models

    doi: 10.1172/JCI172380

    Figure Lengend Snippet: ( A ) Heatmap of amino acid content analyzed by LC-MS in sham- and DMM-operated knee cartilage ( n = 3 and 2, respectively) of mice at 8 weeks after surgery. ( B ) Heatmap of amino acid levels analyzed by LC-MS in chondrocytes treated with or without IL-1β (5 ng/mL) for 36 hours ( n = 4 per group). Ctrl, control. ( C ) Intracellular Gln levels in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours ( n = 3 per group). ( D and E ) Quantitative analysis of qRT-PCR ( n = 4 per group) ( D ) and Western blot ( E ) analysis for the indicated anabolic and catabolic factors in IL-1β–treated chondrocytes supplemented with Gln (4 or 8 mM) for 24 hours. ( F ) Schematic of Gln metabolism. ( G ) Western blot analysis for SLC1A5 and GLS1 in chondrocytes treated with or without IL-1β for 24 hours ( n = 3 per group). ( H ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in joint cartilage of sham- or DMM-operated mice at 8 weeks after surgery ( n = 5 mice per group). Scale bars: 20 μm. ( I ) Representative images of SLC1A5 and GLS1 immunofluorescence and mean intensity in mice fed a standard diet (SD) and those fed an HFD ( n = 5 mice per group). Scale bars: 20 μm. ( J ) Representative images from safranin O staining and SLC1A5 and GLS1 immunofluorescence in undamaged ( n = 10), mildly damaged ( n = 10), and severely damaged (SevD) ( n = 7) human OA cartilage. Scale bars: 20 μm. ( K ) Gln and Glu levels in undamaged (UD) ( n = 10), mildly damaged (MD) ( n = 10) and SevD ( n = 7) human OA cartilage. The correlation between Gln levels and ICRS grading scores is shown in the right column. Scale bars: 200 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: Floxed Gls1 mice ( ) (catalog 017894) and Col2a1-CreERT2 mice ( ) (catalog 006774) were purchased from The Jackson Laboratory.

    Techniques: Liquid Chromatography with Mass Spectroscopy, Control, Quantitative RT-PCR, Western Blot, Immunofluorescence, Staining

    ( A and B ) mRNA ( A ) and Western blot ( B ) analysis of the indicated anabolic and catabolic factors in chondrocytes treated with BPTES or IL-1β alone or with combined BPTES and IL-1β for 24 hours. The culture medium contained 4 mM Gln. Blots are representative of 3 independent experiments. Ctrl, control. ( C ) Representative safranin O/fast green staining images and OARSI scores ( n = 8 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( D ) Representative MMP13 and NOS2 IHC staining images and quantification of cells positive for MMP13 and NOS2 ( n = 5 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( E ) Safranin O/fast green staining and OARSI scores in joint sections of mice at 8 weeks after DMM surgery. Ad-Ctrl or Ad- Gls1 was intra-articularly injected once per week for 3 weeks beginning at 10 days after surgery ( n = 8 mice per group). Scale bars: 20 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: α -Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models

    doi: 10.1172/JCI172380

    Figure Lengend Snippet: ( A and B ) mRNA ( A ) and Western blot ( B ) analysis of the indicated anabolic and catabolic factors in chondrocytes treated with BPTES or IL-1β alone or with combined BPTES and IL-1β for 24 hours. The culture medium contained 4 mM Gln. Blots are representative of 3 independent experiments. Ctrl, control. ( C ) Representative safranin O/fast green staining images and OARSI scores ( n = 8 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( D ) Representative MMP13 and NOS2 IHC staining images and quantification of cells positive for MMP13 and NOS2 ( n = 5 mice per group) in Gls1 −/− mice and their Gls1 fl/fl control littermates at 8 weeks after sham and DMM surgery. ( E ) Safranin O/fast green staining and OARSI scores in joint sections of mice at 8 weeks after DMM surgery. Ad-Ctrl or Ad- Gls1 was intra-articularly injected once per week for 3 weeks beginning at 10 days after surgery ( n = 8 mice per group). Scale bars: 20 μm. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: Floxed Gls1 mice ( ) (catalog 017894) and Col2a1-CreERT2 mice ( ) (catalog 006774) were purchased from The Jackson Laboratory.

    Techniques: Western Blot, Control, Staining, Immunohistochemistry, Injection

    ( A ) IB analysis of K63-linked ubiquitination of TRAF6 in HEK293T cells transfected to express HA-TRAF6 with or without Flag-tagged K63-linked ubiquitin (Flag-K63-Ub) and MYC-tagged UBE2O (MYC-UBE2O). ( B ) Densitometry of the bands in A , showing the ubiquitination (Ub) of TRAF6, presented relative to results obtained with cells transfected to express empty vector, set as 100%. ( C ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 in IL-1β–stimulated chondrocytes in the presence of BPTES. Blots are representative of 3 independent experiments. ( D ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 that was immunoprecipitated and TRAF6 from IL-1β– and DM-αKG–stimulated chondrocytes. ( E ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 immunoprecipitated from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( F ) Protein quantitative analysis of the nuclear p65 from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG for 60 minutes. ( G and H ) Quantitative analysis of qRT-PCR ( G ) and Western blot ( H ) analysis for the indicated anabolic and catabolic factors from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( I ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells at 25 weeks in mice fed a standard diet (SD) or HFD. ( J ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells in Gls1 −/− mice and their Gls1 fl/fl control littermates after DMM surgery. veh, vehicle. ( K ) Schematic depicting the described findings: αKG inhibited the TRAF6 ubiquitination via inducing the expression of UBE2O in OA chondrocytes. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Journal: The Journal of Clinical Investigation

    Article Title: α -Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models

    doi: 10.1172/JCI172380

    Figure Lengend Snippet: ( A ) IB analysis of K63-linked ubiquitination of TRAF6 in HEK293T cells transfected to express HA-TRAF6 with or without Flag-tagged K63-linked ubiquitin (Flag-K63-Ub) and MYC-tagged UBE2O (MYC-UBE2O). ( B ) Densitometry of the bands in A , showing the ubiquitination (Ub) of TRAF6, presented relative to results obtained with cells transfected to express empty vector, set as 100%. ( C ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 in IL-1β–stimulated chondrocytes in the presence of BPTES. Blots are representative of 3 independent experiments. ( D ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 that was immunoprecipitated and TRAF6 from IL-1β– and DM-αKG–stimulated chondrocytes. ( E ) Western blot analysis of K63-linked ubiquitination of endogenous TRAF6 immunoprecipitated from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( F ) Protein quantitative analysis of the nuclear p65 from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG for 60 minutes. ( G and H ) Quantitative analysis of qRT-PCR ( G ) and Western blot ( H ) analysis for the indicated anabolic and catabolic factors from Ad-shCtrl and Ad-shUbe2o chondrocytes stimulated with IL-1β and DM-αKG. ( I ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells at 25 weeks in mice fed a standard diet (SD) or HFD. ( J ) IHC staining for pIκBα, p-p65, and quantification of pIκBα- and p-p65–positive cells in Gls1 −/− mice and their Gls1 fl/fl control littermates after DMM surgery. veh, vehicle. ( K ) Schematic depicting the described findings: αKG inhibited the TRAF6 ubiquitination via inducing the expression of UBE2O in OA chondrocytes. The data are presented as box plots or as the mean ± SEM, and the dots represent biological replicates. * P < 0.05, ** P < 0.01, *** P < 0.001.

    Article Snippet: Floxed Gls1 mice ( ) (catalog 017894) and Col2a1-CreERT2 mice ( ) (catalog 006774) were purchased from The Jackson Laboratory.

    Techniques: Ubiquitin Proteomics, Transfection, Plasmid Preparation, Western Blot, Immunoprecipitation, Quantitative RT-PCR, Immunohistochemistry, Control, Expressing